Tumor Immunology

Tumor immunology explores the intricate relationship between cancer cells and the immune system. It delves into understanding how cancer cells evade immune detection and how the immune system can be harnessed to recognize and destroy tumors. Key areas of study include tumor antigens, immune checkpoint pathways, and immunotherapies. By identifying specific antigens expressed by tumors, researchers aim to develop targeted therapies that enhance immune recognition of cancer cells. Immune checkpoint inhibitors, such as PD-1 and CTLA-4 blockers, unleash the immune system's ability to attack tumors. Additionally, adoptive cell therapies, like CAR-T cells, genetically engineer immune cells to better recognize and kill cancer. Advancements in tumor immunology hold promise for more effective and personalized cancer treatments, offering hope for improved outcomes and quality of life for patients.